Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2398815
Max Phase: Preclinical
Molecular Formula: C40H38N2O8
Molecular Weight: 674.75
Molecule Type: Small molecule
Associated Items:
ID: ALA2398815
Max Phase: Preclinical
Molecular Formula: C40H38N2O8
Molecular Weight: 674.75
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@]12CO[C@@H](c3ccccc3)O[C@H]1CC[C@@]1(C)[C@H]2C[C@H](OC(=O)c2ccc(C#N)cc2)[C@@]2(C)Oc3cc(-c4cccnc4)oc(=O)c3[C@H](O)[C@H]12
Standard InChI: InChI=1S/C40H38N2O8/c1-38-16-15-30-39(2,22-46-37(49-30)25-8-5-4-6-9-25)29(38)19-31(48-35(44)24-13-11-23(20-41)12-14-24)40(3)34(38)33(43)32-28(50-40)18-27(47-36(32)45)26-10-7-17-42-21-26/h4-14,17-18,21,29-31,33-34,37,43H,15-16,19,22H2,1-3H3/t29-,30+,31+,33+,34-,37-,38+,39+,40-/m1/s1
Standard InChI Key: OLMLXIHADMDRSC-WVGFPPCDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 674.75 | Molecular Weight (Monoisotopic): 674.2628 | AlogP: 6.54 | #Rotatable Bonds: 4 |
Polar Surface Area: 141.11 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.84 | CX Basic pKa: 4.21 | CX LogP: 5.10 | CX LogD: 5.10 |
Aromatic Rings: 4 | Heavy Atoms: 50 | QED Weighted: 0.24 | Np Likeness Score: 1.20 |
1. Ohtawa M, Yamazaki H, Ohte S, Matsuda D, Ohshiro T, Rudel LL, Ōmura S, Tomoda H, Nagamitsu T.. (2013) Synthesis and structure-activity relationship of pyripyropene A derivatives as potent and selective acyl-CoA:cholesterol acyltransferase 2 (ACAT2) inhibitors: part 3., 23 (13): [PMID:23711919] [10.1016/j.bmcl.2013.04.075] |
Source(1):